Distance Learning

New Hazardous Waste Pharmaceuticals Rule: Significant Changes Coming for Health Care Facilities, Particularly Long Term Care Facilities - Listen With a Colleague

The “Listen with a Colleague" option allows multiple registrants from the same organization and location to participate in the webinar at a discounted rate. It may ONLY be used if at least one person from your organization and location has registered at the regular/full webinar registration rate. Please note that those who register under the reduced “Listen with a Colleague" rate must access the webinar from the same location and computer as the full-priced registrant they are registered under.

The “Listen with a Colleague" option is continuing legal education (CLE) credit-eligible. In order to obtain a certificate of completion for submission to a state CLE accrediting body, those registered under this option must obtain the attendance verification code—which will be displayed at a random time during the webinar—and enter that code under “Verification Code for Live Webinar" section of the webinar description webpage. Please note that each registrant must submit a complete evaluation from their individual accounts to obtain a certificate of completion.

If you have any questions about this registration option, please contact customer support.

Time: 2:00-3:30 PM Eastern (90 minutes)
Session Format: Listen With a Colleague
CLE Credit Available:  Yes

Understanding EPA’s New Management Standards for Hazardous Waste Pharmaceuticals:  What Health Care Providers Need to Know (and Do)

In an effort to better align the Resource Conservation and Recovery Act (RCRA) standards for hazardous waste with the practical realities of how hazardous waste pharmaceuticals are managed in the health care facility setting, the U.S. Environmental Protection Agency recently promulgated a final rule that establishes a completely new set of management standards for hazardous waste pharmaceuticals in health care facilities. The rule also prohibits the sewering of hazardous waste pharmaceuticals and deletes the hazardous waste listing for certain nicotine replacement therapies.  

The rule applies to a broad array of health care facilities, including hospitals, long-term care facilities, pharmacies, reverse distributors, and others.  While the new requirements present a compliance challenge for all health care facilities covered by the rule, long-term care facilities will face the greatest challenge as they, for the first time, will be required to manage not only their hazardous waste pharmaceuticals, but also their non-pharmaceutical hazardous waste, in accordance with RCRA requirements.
Join your colleagues for an engaging discussion of the requirements of the EPA Hazardous Waste Pharmaceuticals Rule and what the rule means for health care facilities in general, but especially for long-term care facilities.

Level of Difficulty: Intermediate

  • AHLA Member: $99

Content Lead:

  • Post-Acute and Long Term Services Practice Group
  • Registration Closed